Australian Clinical Labs Ltd (acl) Logo

Australian Clinical Labs Ltd (ACL)

___:___ · Healthcare
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE
06/2021
12/2020
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Profitability
NPAT ($) 60,373,000 - - - - - - - - -
NPAT Margin 9.41% -- - - - - - - - -
Return on Equity (ROE) 147.43% 0.00% - - - - - - - -
Return on Assets (ROA) 31.92% 0.00% - - - - - - - -
Valuation
PE Ratio 17.13 0.00 - - - - - - - -
PE Relative to Market 74.4% -- - - - - - - - -
Price to Book 8.38 0.00 - - - - - - - -
Price to Cash Flow 8.37 0.00 - - - - - - - -
Shares Outstanding (M) 201.83 202.33 - - - - - - - -
Market Cap ($M) $686.24 $0.00 - - - - - - - -
Enterprise Value ($M) $945.26 $253.40 - - - - - - - -
Performance
Total Shareholder Return 0.0% -- - - - - - - - -
Relative to Market 0.0% -- - - - - - - - -
Per Share
Earnings 39.69 0.00 - - - - - - - -
Cash Flow 101.20 0.00 - - - - - - - -
Cash 0.17 0.05 - - - - - - - -
Net Tangible Assets (0.15) (0.28) - - - - - - - -
Book Value 0.41 0.23 - - - - - - - -
Share Price $3.40 $0.00 - - - - - - - -
Liquidity
Quick Ratio 0.63 0.45 - - - - - - - -
Current Ratio 0.71 0.54 - - - - - - - -
Efficiency
Asset Turnover 2.70 0.00 - - - - - - - -
Inventory Turnover 96.03 - - - - - - - - -
Working Capital Turnover (91.77) 0.00 - - - - - - - -
Dividends
DPS (c) - - - - - - - - - -
Dividend yield - - - - - - - - - -
Franking - - - - - - - - - -
Gross DPS (c) - - - - - - - - - -
Gross Dividend Yield - - - - - - - - - -
Payout Ratio - - - - - - - - - -
Membership required
Member Content
Source:
Morningstar Logo
06/2021
12/2020
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
INCOME
Trading Revenue 641,311,000 - - - - - - - - -
Other Income 3,357,000 - - - - - - - - -
Total Income Excl. Interest 644,668,000 - - - - - - - - -
INTEREST/FINANCE INCOME
Forex Gain/Loss - - - - - - - - - -
Total Income 644,668,000 - - - - - - - - -
EXPENSES
Expenses (448,069,000) - - - - - - - - -
EBITDA 196,599,000 - - - - - - - - -
DEPRECIATION AND AMORTISATION
Depreciation (88,025,000) - - - - - - - - -
Amortisation (27,000) - - - - - - - - -
Depreciation & Amortisation (88,052,000) - - - - - - - - -
EBIT 108,547,000 - - - - - - - - -
INTEREST/FINANCE EXPENSES
Interest/Finance Income 75,000 - - - - - - - - -
Interest Expense (21,969,000) - - - - - - - - -
Interest Capitalised - - - - - - - - - -
Interest Expenses Incl. Capital (21,969,000) - - - - - - - - -
Net Interest Expenses (21,894,000) - - - - - - - - -
Pre-Tax Profit 86,653,000 - - - - - - - - -
Net Capital Profits - - - - - - - - - -
Pre-Tax Profit Pre-Cap 86,653,000 - - - - - - - - -
TAX
Tax Expenses (26,264,000) - - - - - - - - -
NPAT before Abnormals 60,389,000 - - - - - - - - -
ABNORMALS
Abnormals - - - - - - - - - -
Abnormals Tax - - - - - - - - - -
Net Abnormals - - - - - - - - - -
Non-Controlling Interests (16,000) - - - - - - - - -
Reported NPAT after Abnormals 60,373,000 - - - - - - - - -
NPAT before Capital 60,373,000 - - - - - - - - -
EQUITY
Diluted Shares 201,834,105 202,333,171 - - - - - - - -
Diluted Weighted Shares 152,104,491 202,333,171 - - - - - - - -
Ordinary Dividends - - - - - - - - - -
Preference Dividends - - - - - - - - - -
EPS Adjusted 396,900 - - - - - - - - -
EPS after Abnormals 396,918 - - - - - - - - -
Share of net Profit/Loss - - - - - - - - - -
Membership required
Member Content
Source:
Morningstar Logo
06/2021
12/2020
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Assets
Cash 35,233,000 10,000,000 - - - - - - - -
Receivables 62,976,000 53,700,000 - - - - - - - -
Prepayments 4,612,000 - - - - - - - - -
Inventories 13,356,000 14,200,000 - - - - - - - -
Investments - - - - - - - - - -
Other 1,049,000 6,400,000 - - - - - - - -
Total Current Assets 117,226,000 84,300,000 - - - - - - - -
Non-current assets
Receivables - - - - - - - - - -
Inventories - - - - - - - - - -
PP&E 228,944,000 194,600,000 - - - - - - - -
Investments - 1,000,000 - - - - - - - -
Intangibles Excl. Goodwill 6,923,000 - - - - - - - - -
Goodwill 105,983,000 103,500,000 - - - - - - - -
Future Income Tax Benefit 15,625,000 23,300,000 - - - - - - - -
Other - - - - - - - - - -
Total Non-Current Assets 357,475,000 322,400,000 - - - - - - - -
Total Assets 474,701,000 406,700,000 - - - - - - - -
Current Liabilities
Accounts Payable 42,629,000 40,000,000 - - - - - - - -
Provisions 52,666,000 51,600,000 - - - - - - - -
Short Term Debt 70,206,000 64,200,000 - - - - - - - -
Other 675,000 100,000 - - - - - - - -
Total Current Liabilities 166,176,000 155,900,000 - - - - - - - -
Non-current liabilities
Accounts Payable - - - - - - - - - -
Long Term Debt 224,055,000 199,200,000 - - - - - - - -
Provisions 2,556,000 4,400,000 - - - - - - - -
Other - 100,000 - - - - - - - -
Total Non-Current Liabilities 226,611,000 203,700,000 - - - - - - - -
Total Liabilities 392,787,000 359,600,000 - - - - - - - -
Shareholder Equity
Share Capital 797,975,000 47,100,000 - - - - - - - -
Convertible Equity - - - - - - - - - -
Other Equity - - - - - - - - - -
Reserves ex. Share Premium (778,271,000) - - - - - - - - -
Share Premium Reserves - - - - - - - - - -
Retained Profits 62,194,000 - - - - - - - - -
Total Available Equity Assets 81,900,000 - - - - - - - - -
External Equity
Non-controlling Interests 16,000 - - - - - - - - -
Net Assets 81,914,000 47,100,000 - - - - - - - -
Total Debt 294,261,000 263,400,000 - - - - - - - -
Membership required
Member Content
Source:
Morningstar Logo
06/2021
12/2020
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
OPERATING ACTIVITIES
Receipts 661,967,000 - - - - - - - - -
Payments (450,224,000) - - - - - - - - -
Dividends Received - - - - - - - - - -
Interest Received 75,000 - - - - - - - - -
Interest Paid (39,390,000) - - - - - - - - -
Taxes Paid (18,564,000) - - - - - - - - -
Other - - - - - - - - - -
Net Operating Cash Flow 153,864,000 - - - - - - - - -
INVESTMENT ACTIVITIES
Capital Expend. Excl. Investments (9,506,000) - - - - - - - - -
Payments for Investment - - - - - - - - - -
Payments for Subsidiaries - - - - - - - - - -
Proceeds from PP&E 112,000 - - - - - - - - -
Proceeds from Investments 1,066,000 - - - - - - - - -
Proceeds from Subsidiaries - - - - - - - - - -
Loans Granted - - - - - - - - - -
Loans Repaid - - - - - - - - - -
Other Investments 2,252,000 - - - - - - - - -
Net Investment Cash Flow (6,076,000) - - - - - - - - -
Operating CF less Investment CF 147,788,000 - - - - - - - - -
FINANCING ACTIVITIES
Proceeds from Issues 146,254,000 - - - - - - - - -
Proceeds from Borrowings 321,600,000 - - - - - - - - -
Repayment of Borrowings (269,590,000) - - - - - - - - -
Dividends Paid (42,000,000) - - - - - - - - -
Other Financing Activities (303,634,000) - - - - - - - - -
Net Financing Cash Flow (147,370,000) - - - - - - - - -
Total Net Cashflow 418,000 - - - - - - - - -
CASH
Cash and Cash Equiv. Period Open 34,849,000 - - - - - - - - -
Exchange Rate Adjustments (34,000) - - - - - - - - -
Other Cash Adjustments - - - - - - - - - -
Cash and Cash Equiv. Period Close 35,233,000 - - - - - - - - -
Membership required
Member Content
Source:
Morningstar Logo